SOLAR- Frailty Screening and Multidisciplinary Assessment of Older Adults in the Emergency Department (SOLAR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04629690|
Recruitment Status : Recruiting
First Posted : November 16, 2020
Last Update Posted : February 9, 2021
|Condition or disease||Intervention/treatment||Phase|
|Frailty||Other: SOLAR||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||250 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||Randomised control trial|
|Masking:||Single (Outcomes Assessor)|
|Masking Description:||The outcome assessor will be unaware if the participant was in control or intervention arm|
|Official Title:||The Impact of Frailty Screening of Older Adults With muLtidisciplinary Assessment of Those At Risk During Emergency Hospital Attendance on the Quality, Safety and Cost-effectiveness of Care (SOLAR): a Randomised Controlled Trial|
|Actual Study Start Date :||November 9, 2020|
|Estimated Primary Completion Date :||June 2021|
|Estimated Study Completion Date :||December 2021|
No Intervention: Control Arm
The control group will obtain usual medical care in the Emergency Department and Acute Medical Assessment Unit
Experimental: SOLAR arm
The SOLAR arm will obtain a comprehensive geriatric assessment which will be provided by a geriatric doctor, physiotherapist, occupational therapist, social worker, pharmacist and specialist nurse.
The participants will obtain a multidisciplinary assessment regarding their medical conditions, medication review, cognitive assessment, functional assessment, gait and balance assessment by senior clinicians and a management plan will be implemented.
Other Name: Comprehensive Geriatric Assessment
- Patient Experience Times (PET) [ Time Frame: Exact time of admission or discharge from ED will be collected at 30 days from index visit ]PET time recorded as time of arrival at the ED to discharge or admission
- Time to admission or discharge and if for admission, time that the bed is booked to go to medical wards. [ Time Frame: Exact time of admission or discharge from ED will be collected at 30 days from index visit ]This is the time that the patient is either discharged or identified for admission and bed booked to go to the medical wards
- Rate of ED Representation [ Time Frame: 30 days and 6 months ]A record of the patient coming back to the ED within 30 days and/or 6 months
- Mortality [ Time Frame: 30 days and 6 months ]A record of the patient having died within 30 days or 6 months
- Rate of Hospital Readmission [ Time Frame: 30 days and 6 months ]A record of the patient requiring admission to the hospital within 30 days or 6 months
- Functional Decline [ Time Frame: 30 days and 6 months ]As determined by the Barthel Index. Barthel Index is a score from 0-20. A score of 0 is completely dependent, 20 is fully independent.
- Patient Satisfaction- [ Time Frame: 30 days ]As determined by the Patient Satisfaction Survey III Short Form (PSQ18). This is scored from 18 to 90. 18 being the worst score and 90 being the best score.
- Patient Quality of Life [ Time Frame: 30 days ]As determined by the Euro Quality of Life (Qol) EQ5D. Scored from 0 to 100. 0 is worst imaginable health state with 100 being the best imaginable health state
- Number of visits to family doctor, therapists or public health nurse [ Time Frame: 30 days and 6 months ]Determined by self reported visits to family doctor, allied health services or Public Health Nurse. There will be a telephone consultation at 30 days and 6 months where patients will be asked if they have visited a family doctor, therapist or public health nurse in the previous 30 days at the 30 day telephone call, or 6 months at the 6 month phone call.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04629690
|Contact: Aoife Leahy, Mb Bch BAO||00 353 61 482100 ext email@example.com|
|Contact: Margaret O'Connor, fRCPI||00 353 61 firstname.lastname@example.org|
|University Hospital Limerick||Recruiting|
|Limerick, Ireland, v|
|Contact: Aoife Leahy, MRCPI 061482100 email@example.com|
|Principal Investigator:||Rose Galvin, phD||University of Limerick|